🎯 check Onvansertib (NMS-1286937, NMS-P937) product page
Onvansertib is a potent and highly specific PLK1 inhibitor. It affects PI3K/AKT/mTOR, hypoxia, and DNA repair signaling pathways by inducing G2/M mitotic arrest and chromosomal abnormalities, thereby inhibiting cancer cell proliferation and promoting apoptosis.